tanshinone ii a has been researched along with alkannin in 2 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (alkannin) | Trials (alkannin) | Recent Studies (post-2010) (alkannin) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 6 | 0 | 4 |
| 61 | 0 | 41 | 78 | 1 | 45 |
| Protein | Taxonomy | tanshinone ii a (IC50) | alkannin (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.255 | |
| Pyruvate kinase PKM | Homo sapiens (human) | 0.9 | |
| Class A sortase SrtA | Staphylococcus aureus | 2.68 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
2 other study(ies) available for tanshinone ii a and alkannin
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |